AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharmaceutical Companies

657.063

-2.060-0.31%

Number of Gainers:8

Number of Losers:15

Number of Flat:20

PE:- -

High:668.731

Open:663.741

Low:652.831

Close:659.123

Volume:33.88M

Turnover:180.84M

Market Cap:93.67B

Float Cap:90.54B

Loading ...

US Closing Bell | Stocks retreat as tech-led selloff drags Nasdaq 0.8%

US Closing Bell

Australian Shares Fall; White Cliff Says Hancock Prospecting to Take 13.5% Stake With Nearly AU$9 Million Investment

MT Newswires Live

Immutep's Drug Candidate Now Has Clearer Potential Development Path, Jefferies Says

MT Newswires Live

Immutep Gets a New Bull at Jefferies

Paradigm Biopharmaceuticals Names Chief Medical Officer

MT Newswires Live

Mayne Pharma Signs Five-Year Exclusive Deal With Italfarmaco

MT Newswires Live

Mayne Pharma Group Ltd-Myx Signs Licence Agreement for Blissel in Australia

THOMSON REUTERS

Mayne Pharma Group - Signs Exclusive Five-Year Licence Agreement with Italfarmaco S.a for Blissel in Australia

THOMSON REUTERS

Paradigm Biopharmaceuticals Ltd-DR Daniel Furtner Appointed Chief Medical Officer

THOMSON REUTERS

Prescient Therapeutics Ltd-Prescient Therapeutics - Extension of Share Purchase Plan

THOMSON REUTERS

Australia's Dimerix Rises on Patent Approval in Mexico

ASX Midday Sector Update: Healthcare Stocks Advance, Materials Sector Struggles

MT Newswires Live

Biotron - Michelle Miller Steps Down as Managing Director and CEO

THOMSON REUTERS

Biotron - Board Commences Search for New Leadership Effective Immediately

THOMSON REUTERS

Biotron Ltd-Resignation of Managing Director and Appendix 3Z

THOMSON REUTERS

CitiFirst CSL Instalments Dividend Final Amount-CTW

Dimerix Says Mexican Composition of Matter Patent Granted for Drug Candidate

MT Newswires Live

Dimerix Ltd-Dimerix Dmx-652 Granted Mexican Composition of Matter Patent

THOMSON REUTERS

Noxopharm Ltd-Sof-Skn to Progress to Extension Study in Cle Patients

THOMSON REUTERS

Immutep - to Focus Efti Development on Hnscc with CPS < 1 and Neoadjuvant Sts

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/BK7508/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":657.06305,"timestamp":1789538399653,"preClose":659.12286,"halted":0,"volume":33876933,"delay":0,"changeRate":-0.003125,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-2.059814,"latestTime":"09-16 16:00:00 AEST","open":663.74115,"high":668.7309,"low":652.8311,"amount":180844645,"amplitude":0.024123,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789516800000,1789538400000]],"turnoverRate":0.001328,"increases":8,"decrements":16,"flats":19,"marketCap":93671629289.75,"floatMarketCap":90538125826.625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":668.7309,"amplitude":0.024123,"preClose":659.12286,"low":652.8311,"latestPrice":657.06305,"volume":33876933,"delay":0,"open":663.74115,"prevYearClose":644.3692,"prevWeekClose":634.95,"prevMonthClose":656.138,"prevQuarterClose":464.145,"fiveDayClose":655.041,"twentyDayClose":646.662,"sixtyDayClose":461.734,"secType":"PLATE","market":"AU","turnoverRate":0.001328,"marketCap":93671629289.75,"floatMarketCap":90538125826.625,"timestamp":1789538399653,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":8,"down":15,"flat":20},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1187624168","title":"US Closing Bell | Stocks retreat as tech-led selloff drags Nasdaq 0.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1187624168","media":"US Closing Bell","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187624168?lang=en_us&edition=fundamental","pubTime":"2026-09-16 04:03","pubTimestamp":1789502607,"startTime":"0","endTime":"0","summary":"MarketSeptember 16, U.S. stocks closed lower across the board amid renewed rate-hike anxiety and profit-taking in mega-cap technology names. The Dow Jones Industrial Average fell 0.63%, the S&P 500...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"c1e522724dcc46c8aa3a2b2d1530b6c5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4514","LU1032955483.USD","TYLG","LU0006306889.USD","LU2764263039.SGD","LU0965508806.USD","LU0061474960.USD","NVDO","LU0353189763.USD","LU0943347566.SGD","LU2506951958.HKD","BK4535","LU1934455277.USD","IE00BZ1G4Q59.USD","LU0820562030.AUD","LU0225283273.USD","LU0823414478.USD","LU1489326972.SGD","LU1035773651.USD","IE00BFXG1179.USD","LU2249611893.SGD","HK0000304805.HKD","LU2097344431.USD","LU2491049909.HKD","LU0345770993.USD","IE00B4YYXB79.USD","LU2357627491.SGD","MSTU","LU0726765562.USD","LU1206713676.USD","LU2054465674.USD","09399","LU1861220207.SGD","MSFT","SNPE","LU2092937148.SGD","BK4539","MSDD","BK4598","IE00B775H168.HKD","LU1066053197.SGD","IE00BJJMRY28.SGD","LU2458330243.SGD","LU1979441026.SGD","LU1992135399.USD","LU1814569148.SGD","LU2047632596.USD","MSFD","AMYY","LU1582987597.SGD","HK0000304797.USD","LU1035775433.USD","MSTZ","NVD","VT","BK4097","BK4501","3LMI.UK","LU0289739343.SGD","LU0215105999.USD","COIG","LU0097036916.USD","LU0879622024.SGD","SG9999014542.SGD","LU1116320737.USD","ANV","IE0001KFT4U8.USD","IE00BSNM7G36.USD","NVYY","IE00BN8TJ469.HKD","NVD2.UK","LU2462157665.USD","IE0003U64NQ7.SGD","LU0133085943.USD","LU1989763005.USD","LU1551013425.SGD","BK4141","LU1145028129.USD","LU1670711123.USD","AMDU","LU0354030511.USD","IE00BQXX3D17.EUR","LU2098885051.SGD","HK0000914686.HKD","LU2242650005.HKD","SMHX","LU1582986359.USD","LU0433182093.SGD","LU1188199696.SGD","BK4588","IE0004445239.USD","AVGO","IE00BLSP4239.USD","LU0395794307.EUR","LU0353189680.USD","LU0788109477.HKD","LU1551013342.USD","LU1429558221.USD","LU0985489474.SGD","SG9999001440.SGD","LU1564329628.SGD","LU0757359954.USD","AMDS","LU0823421416.USD","CNAV","LU0690374961.EUR","LU0107464264.USD","LU2125909593.SGD","LU2244417387.USD","CAN","IE00B775SV38.USD","FTEC","AGOX","LU1778281490.HKD","BK4595","NVDL","AAPY","LU0210536198.USD","LU0689472784.USD","SGXZ80539844.SGD","IE00B7SZLL34.SGD","LU1400636491.USD","LU1868836591.USD","3NVD.UK","LU1496350171.SGD","LU0265550946.USD","LU2543165471.USD","LU2089283258.USD","LU0234570918.USD","LU1046421795.USD","LU2860962120.EUR","LU0545039389.USD","LU1084165304.USD","LU1803068979.SGD","LU2211814178.USD","BK4503","LU0323239441.USD","LU2360107671.USD","LU0211328371.USD","LU2430703178.SGD","NULC","LU2092627202.USD","SAAPLmain","LU0096362180.USD","LU0511384066.AUD","RETO","LU2461242641.AUD","LU0348723411.USD","LU2237443895.HKD","SG9999000418.SGD","BK4577","CGBL","LU1066051498.USD","SG9999003800.SGD","LU1548497426.USD","BK4605","BK4011","LU0323240290.USD","TDIV","07311","09799","IE0009G5SDU7.USD","IE00BFSS8Q28.SGD","LU2148611432.USD","LU0823417737.USD","LU0127658192.USD","SG9999015978.USD","LU0792757196.USD","IE00BLSP4452.SGD","LU1720051017.SGD","LU1691799644.USD","SOXQ","IOSX","BK4579","LU0820561909.HKD","LU2083900584.USD","CHAT","LU2168564495.EUR","LU2023251221.USD","LU1670711040.USD","DAMD","LU0265550359.USD","LU0316494557.USD","LU2063271972.USD","MSTY","SG9999015986.USD","LU0724617625.USD","LU0289941410.SGD","IE000KEQY171.SGD","NVDW","AVGC","LU0138981039.USD","LU2463028550.USD","SG9999001424.SGD","LU1923622614.USD","LU0994945656.USD","IE00BFXG0V08.USD","LU1868836757.USD","AIFD","BK4533","LU0898699433.AUD","LU0456855351.SGD","LU2361045086.USD","LU0048584097.USD","LU0106261372.USD","BLCK","LU1066051811.HKD","LU0528227936.USD","NVDS.UK","IE00B5949003.HKD","LU1791710400.SGD","07399","NVDU","LU2360032135.SGD","LU1861217088.USD","AMDD","AMDG","LU0096364046.USD","LU1917777945.USD","LU2087621335.USD","IE00BMPRXN33.USD","LU0061474705.USD","BK4532","LU1069347547.HKD","SG9999014567.USD","LU0347712357.USD","LU1951200564.SGD","LU2191332357.HKD","SAMD0main","SGXZ99366536.SGD","LU0154236417.USD","CNEQ","LU2023250504.SGD","LU2552382215.SGD","TRFK","LU1815336760.USD","AMD","BK4516","LU2247934214.USD","MSOO","LU1236620834.HKD","LU2592432038.USD","IE0009356076.USD","LU1032466523.USD","LU1074936037.SGD","LU1935043452.HKD","LU0472753341.HKD","LU2756315318.SGD","LU1242518857.USD","LU2357125470.USD","AVGG","LU2326559502.SGD","LU1400636574.HKD","LU0738911758.USD","LU1244550494.USD","WUGI","LU0784385170.HKD","LU0784385840.USD","TTXU","LU2347655156.SGD","LU0868494708.USD","LU0683600562.USD","LU0203202063.USD","LU2360107168.USD","LU1119994496.HKD","LU1718418525.SGD","LU1674673691.USD","EPOW","BK4576","LU0256863902.USD","AMDC","ORCS","LU1880398471.USD","ESLG","LU0345769128.USD","HK0000320223.HKD","IE0005OL40V9.USD","LU2168564222.USD","LU0077335932.USD","LU2213496289.HKD","LU0690374615.EUR","IE00BVYPNP33.GBP","LU1839511570.USD","LU1914381329.SGD","LU1670756490.USD","IE00BKPKM429.USD","AVGW","MRVL","BK4112","LU2413666426.HKD","LU0266013472.USD","LU2125909247.SGD","LU0081259029.USD","FXL","IETC","ROM","LU0757359368.USD","IE00B19Z3B42.SGD","BK4510","09388","LU1861220033.SGD","LU2471134879.HKD","LU2023250843.SGD","IE00BQXX3C00.GBP","LU1670628061.USD","LU0345774631.USD","LU0708994859.HKD","SG9999015952.SGD","LU1571399168.USD","LU2272731782.SGD","APED","LU2279689827.SGD","LU0957808578.USD","LU2089284900.SGD","YQ","LU0784383803.USD","LU0964807845.USD","BK4538","LU0345770308.USD","LU1712237335.SGD","LU0642271901.SGD","LU2322448957.HKD","LU0894485498.HKD","CHPS","FDTX","LU0354030438.USD","IE0002270589.USD","LU1989764748.USD","AIPI","IE00BBT3K403.USD","BK4608","LU0985320562.USD","LU2065170008.USD","LU2125154935.USD","LU3102509885.SGD","LU0640476718.USD","IE00B1XK9C88.USD","LU0072462426.USD","BK4559","LU0070217475.USD","IE00B19Z9505.USD","IE00BDCRKT87.USD","BK4550","LU0965509283.SGD","LU1366192091.USD","LU2430703095.HKD","LU2106854487.HKD","MVLL","SAVGOmain","LU0689626769.HKD","2NVD.UK","LU1037948541.HKD","LU1803068623.USD","LU1934455863.HKD","LU2462591277.SGD","LU2362541513.USD","LU2360106780.USD","LU1670710661.SGD","LU2471134796.USD","LU1852331112.SGD","IE00B4JS1V06.HKD","LU2237443978.SGD","IE000YTNTUN2.SGD","BK4529","LU2361044865.SGD","FCOM","LU0029864427.USD","SG9999014914.USD","AAPD","LU1861559042.SGD","BK4567","LU1059921491.USD","MSTP","LU1064131342.USD","LU1821325948.USD","LU1301847155.USD","LU1868837136.USD","LU2210149790.SGD","LU1815333072.USD","LU0175139822.USD","LU1823568750.SGD","LU0345769631.USD","LU1003077747.HKD","IE00BDGV0183.EUR","LU2720916845.USD","NVD3.UK","LU1732799900.SGD","MSTY.UK","IE00B7KXQ091.USD","IGV","LU0109392836.USD","LU0174119429.USD","LU1228905540.USD","LU1236620750.USD","LU1244550221.USD","LU0942090050.USD","LU2065171402.SGD","IE00B19Z9Z06.USD","THMR","BK4571","LU0208291251.USD","LU1868836914.USD","MSTK","SNVDAmain","LU0267386448.USD","NVIW.SI","IE00B19Z8X17.USD","LU0069063385.USD","LU1291159041.SGD","LU1983260115.SGD","LU0476273544.USD","IE00BVYPNV92.GBP","LU1162221912.USD","IE00B19Z9P08.USD","LU1221951129.SGD","FIAT","IE000M9KFDE8.USD","LU0868494617.USD","LU2097829019.USD","LU0187121727.USD","LU0949170772.SGD","LU2458330169.SGD","MSFU","MSFL","LU2102340556.USD","LU1235294995.USD","LU2413666699.HKD","METV","MSFO","GOOX","NVDS","IXN","BK4123","LU1261432733.SGD","SG9999018865.SGD","LU2111349929.HKD","BK4526","AMDY","IE000F7OJYX1.SGD","IE000Q6AESB8.SGD","LU1791710582.SGD","LU2100268510.USD","LU0171293334.USD","NVC","BK4515","CONY","BK4592","DIPS","LMI3.UK","IE00BJLML261.HKD","COYY","LU1037948897.HKD","LU0871640123.AUD","AVS","LU1242518931.SGD","LU1923623000.USD","LU2505996681.GBP","SGXZ31699556.SGD","AAPB","LU1923622291.USD","LU0648001328.SGD","TRUC","BK4548","LU2473716301.USD","LU0912757837.SGD","LU1935042991.SGD","LU1221951046.USD","MSFX","LU0784384876.USD","SG9999014906.USD","HK0000914660.USD","IE0004086264.USD","LU2089985449.USD","LU1674673428.USD","LU2250418816.HKD","IE00BVYPNW00.USD","LU0289961442.SGD","LU1196500208.SGD","BK4585","LU1400636657.SGD","HLP","MSFW","LU0494093205.USD","LU2602419157.SGD","IE00BKVL7J92.USD","GB00BDT5M118.USD","USJW.SI","LU0444971666.USD","CLSE","COIW","LU1066051225.USD","GB00B4QBRK32.GBP","LU1435385759.SGD","AAPU","LU0889565833.HKD","BK4006","IE00BZ9MQY76.HKD","CMAG","LU0787776722.HKD","LU0960925559.SGD","SG9999015341.SGD","LU1127390331.HKD","BK4077","LU2999663052.SGD","AMDW","LU0466842654.USD","LU2290526834.HKD","LU0557290698.USD","LU2404859667.USD","IE00BK4W5L77.USD","LU0203347892.USD","IE00B3M56506.USD","LU0957791311.USD","LU0320765489.SGD","BK4573","LU0310799852.SGD","IE000W1ABFV2.USD","LU1861127337.USD","AMUU","LU0211331839.USD","LU2023250330.USD","LU1645745479.HKD","NVDA","BK4023","LU2168564065.EUR","IE00BZ199S13.USD","LU0210528500.USD","BK4614","LU2394011477.USD","LU2133065610.SGD","LU1935042488.USD","LU2404859741.USD","QQQA","BK4549","IE0004445015.USD","SG9999004303.SGD","LU0889566641.SGD","LU2381873111.SGD","LU1699723380.USD","LU0289960550.SGD","LU0314104364.USD","LU0823434583.USD","SG9999015945.SGD","LU2506952097.USD","09711","NVDQ","LU2471134523.USD","LU2275660780.HKD","LU2362541273.HKD","ORCX","LU0417517546.SGD","LU1935043023.USD","OWNB","NVII","IE00BQXX3F31.USD","IE00B1BXHZ80.USD","LU1989764664.SGD","LU2552382132.HKD","CONX","LU1228905037.USD","LU0080751232.USD","LU2125154778.USD","ILDR","LU1935042215.USD","LU0426412945.USD","LU0070302665.USD","LU2491050071.SGD","MSTX","IE00BN29S564.USD","LU2954938101.SGD","WISE","LU1721428933.USD","IE00B5TLWC47.USD","LU2347655073.USD","MSTR.AU","SGOOGmain","NVDX","LU0109391861.USD","ORAC","BK4528","LU1585245621.USD","SOXY","HK0000532082.HKD","LU2237957811.SGD","LU1934455194.USD","EFIV","LU2896262040.SGD","COIA","LU0256863811.USD","LU1334329650.SGD","IE00B42XCP33.USD","OGIG","LU2265009873.SGD","IE00BHPRN162.USD","VGT","CONI","SG9999014898.SGD","IE00BK4W5M84.HKD","LU2764263203.CNY","BK4505","LCLG","LU2362540622.SGD","SG9999001077.SGD","LU0345768740.USD","SHOC","IE00BVYPNQ40.USD","LU0545562505.USD","DTCR","07711","MSII","LU1642822529.SGD","BK4596","LU0211327993.USD","AAPW","LU0345774391.USD","IE00BJJMRX11.SGD","SG9999018857.SGD","BK4553","LU1316542783.SGD","ABFL","LU0276348264.USD","IE000ITXATA3.USD","LU2471134952.CNY","LU2764262908.HKD","LU0198837287.USD","LU1323610961.USD","ARTY","LU0661504455.SGD","LU0061475181.USD","09788","SMSFTmain","NVDD","HAKY","LU0345768153.USD","LU0878866978.SGD","NQmain","LU1582986433.USD","LU1989772840.SGD","LU2242649171.HKD","LU2360108059.USD","LU2552382058.USD","NVDB","LU0068578508.USD","IE000MB6IJN5.SGD","MRVX","BK4574","HK0000819398.USD","IE00BYQQ9H92.USD","LU0708995401.HKD","LU1121112475.USD","LU1496350502.SGD","LU2237443382.USD","COIX","LU0553294199.USD","LU0011850046.USD","LU0128525929.USD","LU0979878070.USD","LU2065171311.SGD","LU0795875169.SGD","BK7502","LU2430703251.USD","IE00BKDWB100.SGD","ORCL","LU2125909759.SGD","07788","LU0170899867.USD","BK4512","LU1303367103.USD","BK4566","LU1720051108.HKD","LU1267930730.SGD","LU1623119135.USD","07799","LU2028103732.USD","ESUM","GTEK","LU1043141396.HKD","BK4551","LU1629891620.HKD","BK4581","LU0342679015.USD","USD","WNTR","LU2322448791.USD","IE0034235188.USD","BK4612","FAI","LU2746668974.SGD","IE00BMCWC346.EUR","LU2298321311.HKD","BK7504","09311","AAPX","LU1043141123.HKD","LU2237443622.USD","IE00BJTD4V19.USD","LU0965509101.SGD","LU1880398554.USD","LU2077746001.SGD","LU0823414551.USD","LU1153585028.USD","AIQ","LU1069344957.HKD","LU1232071149.USD","COII","SG9999011175.SGD","LU1564329032.USD","LU2264538146.SGD","JGRO","LU0130102774.USD","CAN.AU","LU1633808545.USD","MSST","SMI3.UK","BK4504","LU0882574139.USD","LU2168564149.EUR","LU2487616109.SGD","PSI","LU0786609619.USD","NVDG","BK4543","LU2506952170.USD","IE0034235303.USD","MSFC","BK4587","LU0894486033.HKD","LU1989772923.USD","SG9999014880.SGD","BK4507","LU0444973449.USD","LU2361044949.HKD","LU0158827948.USD","IE00BYV24P56.USD","LU2357305700.SGD","LU2506951875.HKD","SG9999014575.USD","GB00B4LPDJ14.GBP","IE00BGHQDM52.EUR","LU2065169927.USD","LU1989771016.USD","LU0095938881.EUR","FDIG","SG9999015358.SGD","LU2462591350.SGD","LU0210533765.USD","LU2125909916.SGD","MSTR","AVGX","LU0308772762.SGD","HK0000306701.USD","LEGR","GOOG","LU2456880835.USD","LU2097344357.USD","LU0965509010.AUD","LU1989773731.SGD","BK4170","SORCLmain","SG9999002224.SGD","BK7096","GOOP","IMST","LU0795875086.SGD","LU0980610538.SGD","LU1861215975.USD","LU2041044095.USD","AIS","IE000BZT7R73.USD","LU0274383776.USD","LU2237957902.USD","LU1144417596.USD","LU1267930573.SGD","MTYY","ORCU","LTL","LU2506951792.HKD","XLK","LU1181866309.USD","COIO","BK4525","LU2420271590.USD","AAPE","SG9999014559.SGD","LU2237443549.SGD","SPTE","BK7508","IBLC","HK0000306685.HKD","LU1201861249.SGD","BK4575","LU1267930813.SGD","LU1506573853.SGD","IE000WAW04H5.SGD","LU1202635105.USD","LU1206712785.SGD","BAI","LU1235295455.SGD","APLY","LU2452424414.USD","BK4554","SGXZ23171101.USD","HK0000320264.USD","CHPX","LU1935043536.SGD","LU2236285917.USD","LU2294711713.HKD","AMDL","LU0056508442.USD","3SMI.UK","BK4602","IE00BD6J9T35.USD","LU2750360641.GBP","IE00B3PB1722.GBP","FTXL","LU2286300806.USD","LU2756315664.SGD","LU0072461881.USD","LU0320765646.SGD","LU0157215616.USD","SOXX","IE0000B7K699.USD","LU1340139317.AUD","LU2637965513.SGD","LU1868837300.USD","LU0320765059.SGD","LU0234572021.USD","LU2931357623.SGD","GAMR","LU0251132253.USD","LU0302445910.USD","LU0053666078.USD","LU2750360997.AUD","IE00BDRTCR15.USD","BK4204","LU2505996509.AUD","LU1951198990.SGD","IE00B3S45H60.SGD","LU1564329461.SGD","LU2355687059.USD","LU0859254822.USD","GXPC","LU1732800096.USD","IE00B19Z8W00.USD","IE000SO60NU8.SGD","LU0426417589.USD","LU1169589451.USD","MSTW","SMST","LU1564329115.USD","ORCZ","XNTK","LU1992135472.HKD","IE00B894F039.SGD","ICOI","AMD.AU","IE00B3SWFQ91.USD","LU0312595415.SGD","LU0949170426.SGD","SGXZ51526630.SGD","DAPP","LU0149725797.USD","AVGU","LU0203201768.USD","LU2211815571.USD","LU2417539215.USD","CONL","LU2271345857.HKD","IE0034235295.USD","LU0124676726.USD","LU1116320901.HKD","LU1974910355.USD","LU0719512351.SGD","LU2092937221.SGD","LU2237443465.HKD","LU2403377893.USD","FINX","LU2746668461.USD","CGDG","LU0672654240.SGD","LU1267930490.SGD","LU1366333091.USD","MST","LU1430594728.SGD","LU0820561818.USD","SG9999002232.USD","IE00BJTD4N35.SGD","LU0950375773.USD","LU1670627923.USD","LU2491050154.USD","IE00BFSS7M15.SGD","LU2237438978.USD","LU0143551892.USD","IE00BYXW3230.USD","LU2108987350.USD","COIN","IE0004091025.USD","LU2433249047.HKD","LU0310800379.SGD","LU0390134368.USD","LU1244550577.SGD","LU2210150020.SGD","MRVU","IE00B19Z3581.USD","LU0094547139.USD","LU2272731600.USD","BK4527","USXF","BK7095","VOX","BK4600","TEK","LU0162691827.USD","LU0823434740.USD","LU1582987324.SGD","BK4604","CGGO","IE00BMPRXQ63.HKD","BK4096","LU0823417653.USD","LU0079474960.USD","LU0314106906.USD","LU0823421333.USD","LU1697837992.HKD","AVL","LU2095319765.USD","TTEQ","LU0323591593.USD","CIBR","NVDY","MACW.SI","LU0238689110.USD","LU0057025933.USD","LU1861558580.USD","LU0158827781.USD","LU1169590202.USD","LU2168563687.JPY","LU2272731865.HKD","IE00BWXC8680.SGD","LU0082616367.USD","LU1804176565.USD","LU1670710588.SGD","LU1280957306.USD","AAPL","IE00BMPRXR70.SGD","IE00BGHQF631.EUR","LU0203345920.USD","MSTC","SGXZ81514606.USD","LU0861579265.USD","SNVD.UK","XLC","07388","MSFY","BK4534","SMH","SG9999017495.SGD","LU1988902786.USD","LU2087625088.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667611515","title":"Australian Shares Fall; White Cliff Says Hancock Prospecting to Take 13.5% Stake With Nearly AU$9 Million Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2667611515","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667611515?lang=en_us&edition=fundamental","pubTime":"2026-09-15 14:23","pubTimestamp":1789453413,"startTime":"0","endTime":"0","summary":"Australian shares closed lower on Tuesday, tracking losses on Wall Street as the prospect of a rate hike in the US loomed.The S&P/ASX 200 Index fell by 0.88%, or 77.40 points, to close at 8,672.50, re","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GEAR.AU","IOZ.AU","IMLC.AU","MYX.AU","BBOZ.AU","BK7096","IISV.AU","EIGA.AU","WCN.AU","IIGF.AU","XAO.AU","ZYAU.AU","SLF.AU","HBHC","DACE.AU","OZR.AU","QFN.AU","BK7508","OZF.AU","VAS.AU","XJO.AU","QRE.AU","GIVE.AU","XKO.AU","STW.AU","NIC.AU","E200.AU","BK7095","VAP.AU","BEAR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667616451","title":"Immutep's Drug Candidate Now Has Clearer Potential Development Path, Jefferies Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2667616451","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667616451?lang=en_us&edition=fundamental","pubTime":"2026-09-15 13:33","pubTimestamp":1789450429,"startTime":"0","endTime":"0","summary":"Immutep's  eftilagimod alfa drug candidate, or efti, now has a clearer potential development path after the early termination of the TACTI-004 study, according to a Tuesday note by Jefferies.Its root cause analysis increasingly supports TACTI-004 as a potentially isolated product-specific structural issue rather than a failure of efti's biology. The identification of subtle N-glycan differences in the efti material used in TACTI-004 is potentially important.With prior efti data intact, head and neck squamous cell carcinoma prioritization, fast-track status, and planned manufacturing work, the risk and reward look more constructive despite residual execution risk.The brokerage upgraded its rating on Immutep to buy from hold with the price target rising to AU$0.08 per share from AU$0.04.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7067","IMM.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667692474","title":"Immutep Gets a New Bull at Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2667692474","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667692474?lang=en_us&edition=fundamental","pubTime":"2026-09-15 09:09","pubTimestamp":1789434540,"startTime":"0","endTime":"0","summary":"0109 GMT - Immutep gets a new bull at Jefferies, where analyst David Stanton sees a clearer potential development path for the biotechnology company's lead product candidate. Raising his recommendation to buy from hold, Stanton is encouraged by the Australian company's update that the early discontinuation of a lung cancer study doesn't appear to be linked to clinical factors or trial execution. Emerging evidence supports a cautiously constructive view that the outcome stemmed from an isolated manufacturing or product-characterisation issue, Stanton explains in a note to clients. Risk/reward looks more constructive to Stanton, who now includes Immutep's phase IIhead and neck squamous cell carcinoma opportunity in his valuation. Jefferies doubles its target price to 8 Australian cents. Shares are flat at 4.7 Australian cents.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMMP","IMM.AU","BK7067","BK4139","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667947016","title":"Paradigm Biopharmaceuticals Names Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2667947016","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667947016?lang=en_us&edition=fundamental","pubTime":"2026-09-15 08:39","pubTimestamp":1789432751,"startTime":"0","endTime":"0","summary":"Paradigm Biopharmaceuticals  appointed Daniel Furtner as its Chief Medical Officer, effective Wednesday, according to a Tuesday Australian bourse filing.Furtner succeeds Donna Skerrett, who will remain with the firm as a senior scientific advisor.Furtner previously served as the senior director of medical affairs for the Asia Pacific region at CSL.Its shares fell 2% in recent trading on Tuesday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","PAR.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667250694","title":"Mayne Pharma Signs Five-Year Exclusive Deal With Italfarmaco","url":"https://stock-news.laohu8.com/highlight/detail?id=2667250694","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667250694?lang=en_us&edition=fundamental","pubTime":"2026-09-15 08:32","pubTimestamp":1789432343,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group  has entered into an exclusive five-year agreement with Italfarmaco to register, market and distribute Blissel, an ultra-low-dose vaginal gel for menopause-related vaginal atrophy, in Australia, according to a Tuesday Australian bourse filing.Blissel is targeted for launch in fiscal 2028 through the company's existing women's health commercial team, expanding its menopause portfolio alongside NEXTSTELLIS, per the filing.Australia's topical vaginal estrogen market is worth around AU$27 million in 2025, growing at a 16% two-year compound annual growth rate, with the company expecting Blissel to contribute to international sales, the filing added.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7096","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667691491","title":"Mayne Pharma Group Ltd-Myx Signs Licence Agreement for Blissel in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2667691491","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667691491?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:51","pubTimestamp":1789429863,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUE3VY8ZX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BK7508","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667496691","title":"Mayne Pharma Group - Signs Exclusive Five-Year Licence Agreement with Italfarmaco S.a for Blissel in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2667496691","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667496691?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:51","pubTimestamp":1789429863,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUE3VY8ZX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667911446","title":"Paradigm Biopharmaceuticals Ltd-DR Daniel Furtner Appointed Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2667911446","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667911446?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:47","pubTimestamp":1789429621,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUE69ZBXD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PAR.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667569924","title":"Prescient Therapeutics Ltd-Prescient Therapeutics - Extension of Share Purchase Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2667569924","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667569924?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:00","pubTimestamp":1789426817,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUEBBQWSP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTX.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667632159","title":"Australia's Dimerix Rises on Patent Approval in Mexico","url":"https://stock-news.laohu8.com/highlight/detail?id=2667632159","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667632159?lang=en_us&edition=fundamental","pubTime":"2026-09-14 11:59","pubTimestamp":1789358350,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Dimerix rises on patent approval in Mexico** Shares of Australia's DimerixDXB.AXrise as much as 10% to A$0.275, marking their biggest pct gain since August 20** Clinical-stage biopharmaceutical company says Mexico has granted a patent for DMX-652, a drug candidate for acute kidney injury** The patent expands protection for DMX-652 in Mexico, one of Latin America's largest pharmaceutical markets** Co says the approval strengthens the commercial potential of DMX-652, following a similar approval for the drug in U.S.** YTD down 53.6%, including the session's moves","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4N45604Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXB.AU","BK7067","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667563433","title":"ASX Midday Sector Update: Healthcare Stocks Advance, Materials Sector Struggles","url":"https://stock-news.laohu8.com/highlight/detail?id=2667563433","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667563433?lang=en_us&edition=fundamental","pubTime":"2026-09-14 10:38","pubTimestamp":1789353499,"startTime":"0","endTime":"0","summary":"Healthcare stocks advanced 1% at midday Monday.CSL (ASX:CSL) gained nearly 2% in recent trade.On the flip side, the materials sector struggled, shedding nearly 1%.BHP Group (ASX:BHP) shares fell past 1% in recent trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","HCSG","BHP.AU","BK4581","LU0128526141.USD","BK7507","XBI","BK4585","BK7511","BK7095","BK4588","BK4137","BK7067","LU0029874061.USD","UYM","XLV","BK7508","CSL.AU","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667636149","title":"Biotron - Michelle Miller Steps Down as Managing Director and CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2667636149","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667636149?lang=en_us&edition=fundamental","pubTime":"2026-09-14 08:36","pubTimestamp":1789346171,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUE3HYPDN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7501","BIT.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667636146","title":"Biotron - Board Commences Search for New Leadership Effective Immediately","url":"https://stock-news.laohu8.com/highlight/detail?id=2667636146","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667636146?lang=en_us&edition=fundamental","pubTime":"2026-09-14 08:36","pubTimestamp":1789346171,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUE3HYPDN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7508","BK7067","BIT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667563614","title":"Biotron Ltd-Resignation of Managing Director and Appendix 3Z","url":"https://stock-news.laohu8.com/highlight/detail?id=2667563614","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667563614?lang=en_us&edition=fundamental","pubTime":"2026-09-14 08:36","pubTimestamp":1789346171,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUE3HYPDN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIT.AU","BK7067","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667636275","title":"CitiFirst CSL Instalments Dividend Final Amount-CTW","url":"https://stock-news.laohu8.com/highlight/detail?id=2667636275","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667636275?lang=en_us&edition=fundamental","pubTime":"2026-09-14 08:32","pubTimestamp":1789345953,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260914:nASX9H7YgV","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nASXcdLQt8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","CSL.AU","BK7508","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667368026","title":"Dimerix Says Mexican Composition of Matter Patent Granted for Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2667368026","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667368026?lang=en_us&edition=fundamental","pubTime":"2026-09-14 08:06","pubTimestamp":1789344401,"startTime":"0","endTime":"0","summary":"Dimerix  said the Mexican Institute of Industrial Property  granted a key composition of matter patent covering its drug candidate, DMX-652, according to a Monday Australian bourse filing.The patent grant \"N-cyanopyrrolidines with activity as USP30 inhibitors\" was issued under patent number 438406 and provides composition of matter protection for DMX-652 until June 3, 2041.The company's planned phase 2 study of DMX-652 in cardiac surgery-associated acute kidney injury will investigate the candidate's potential to prevent kidney injury and preserve renal function.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DMX","BK7501","BK7067","BK7508","DXB.AU","USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667633298","title":"Dimerix Ltd-Dimerix Dmx-652 Granted Mexican Composition of Matter Patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2667633298","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667633298?lang=en_us&edition=fundamental","pubTime":"2026-09-14 06:39","pubTimestamp":1789339172,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260913:nTUE3BDS1R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","BK7501","DXB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667163349","title":"Noxopharm Ltd-Sof-Skn to Progress to Extension Study in Cle Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2667163349","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667163349?lang=en_us&edition=fundamental","pubTime":"2026-09-14 06:23","pubTimestamp":1789338203,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260913:nTUE5TRD03:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NOX.AU","BK7067","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666521234","title":"Immutep - to Focus Efti Development on Hnscc with CPS < 1 and Neoadjuvant Sts","url":"https://stock-news.laohu8.com/highlight/detail?id=2666521234","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666521234?lang=en_us&edition=fundamental","pubTime":"2026-09-11 20:00","pubTimestamp":1789128036,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nFWN4530F5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMM.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":71,"code":"91000000","status":"200"}]}}